Xin Lang Cai Jing·2025-09-24 05:41Group 1 - The core viewpoint of the news is that Nuo Cheng Jian Hua's stock has increased by 5.02%, reaching a price of 28.88 yuan per share, with a total market capitalization of 50.963 billion yuan [1] - Nuo Cheng Jian Hua is a Chinese biopharmaceutical company established on November 3, 2015, focusing on the research, production, and commercialization of drugs, particularly in oncology and autoimmune diseases [1] - The company's revenue composition includes 87.67% from drug sales, 12.04% from technology licensing, and 0.15% each from testing and research services [1] Group 2 - According to data, Zhongyin Fund has a significant holding in Nuo Cheng Jian Hua, with its Zhongyin Healthcare Mixed A Fund reducing its stake by 1.0453 million shares in the second quarter, now holding 1.2264 million shares, which represents 4.19% of the fund's net value [2] - The Zhongyin Healthcare Mixed A Fund has achieved a return of 80.44% year-to-date, ranking 216 out of 8173 in its category, and a one-year return of 110.4%, ranking 433 out of 7996 [2] Group 3 - The fund manager of Zhongyin Healthcare Mixed A is Zheng Ning, who has been in the position for 3 years and 87 days, with the fund's total asset size at 5.838 billion yuan [3] - During Zheng Ning's tenure, the best fund return was 99.6%, while the worst return was 62.14% [3]